Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON38372Recruiting
Randomised trial of methylphenidate, levodopa + carbidopa and Placebo-COD Research Private Ltd (3 arms), sponsored by Maastricht University. Primary endpoints: Contingent Negative Variation amplitude, Response time on response preparation tasks and 7 more. Started Jan 2011; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON38372.